Recruiting Pulmonary Hypertension Studies in Auckland
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy
The goal of this clinical trial is to learn how safe and tolerable EPI-321 is and whether there may be early signs it is working in male or female adult (18 to 75 years) participants with facioscapulo...
About Pulmonary Hypertension Clinical Trials in Auckland
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 2 pulmonary hypertension clinical trials recruiting participants in Auckland, . These studies are seeking a combined 69 participants. Research is being sponsored by Hoffmann-La Roche, Epicrispr Biotechnologies, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Auckland — FAQ
Are there pulmonary hypertension clinical trials in Auckland?
Yes, there are 2 pulmonary hypertension clinical trials currently recruiting in Auckland, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Auckland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Auckland research site will contact you about next steps.
Are clinical trials in Auckland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Auckland studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 2 active trials in Auckland are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov